In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum
- PMID: 18391027
- PMCID: PMC2415809
- DOI: 10.1128/AAC.00176-08
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum
Abstract
A microdilution method was used to test 11 antifungal drugs against clinical isolates of Fusarium thapsinum and three different phylogenetic clades of Fusarium verticillioides that were characterized by sequencing a region of the beta-tubulin gene. Terbinafine was the most-active drug against both species, followed by posaconazole against F. verticillioides.
Figures

Similar articles
-
Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility.J Clin Microbiol. 2009 May;47(5):1463-8. doi: 10.1128/JCM.02467-08. Epub 2009 Mar 25. J Clin Microbiol. 2009. PMID: 19321723 Free PMC article.
-
Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.Antimicrob Agents Chemother. 2008 Jul;52(7):2683-5. doi: 10.1128/AAC.00272-08. Epub 2008 Apr 28. Antimicrob Agents Chemother. 2008. PMID: 18443107 Free PMC article.
-
Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.J Antimicrob Chemother. 2008 Apr;61(4):805-9. doi: 10.1093/jac/dkn022. Epub 2008 Feb 8. J Antimicrob Chemother. 2008. PMID: 18263569
-
Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.Mycopathologia. 2018 Jun;183(3):529-540. doi: 10.1007/s11046-018-0248-7. Epub 2018 Feb 14. Mycopathologia. 2018. PMID: 29445920
-
Posaconazole: a broad-spectrum triazole antifungal.Lancet Infect Dis. 2005 Dec;5(12):775-85. doi: 10.1016/S1473-3099(05)70297-8. Lancet Infect Dis. 2005. PMID: 16310149 Review.
Cited by
-
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?J Clin Microbiol. 2009 Apr;47(4):877-84. doi: 10.1128/JCM.01685-08. Epub 2008 Dec 10. J Clin Microbiol. 2009. PMID: 19073865 Free PMC article. Review. No abstract available.
-
Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience.Open Forum Infect Dis. 2015 Jul 4;2(3):ofv099. doi: 10.1093/ofid/ofv099. eCollection 2015 Sep. Open Forum Infect Dis. 2015. PMID: 26258156 Free PMC article.
-
Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment.Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1491-500. doi: 10.1007/s10096-013-1924-7. Epub 2013 Aug 11. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23934595 Review.
-
Antifungal Susceptibility Testing of Fusarium: A Practical Approach.J Fungi (Basel). 2017 Apr 26;3(2):19. doi: 10.3390/jof3020019. J Fungi (Basel). 2017. PMID: 29371537 Free PMC article. Review.
-
Fusarium musae from Diseased Bananas and Human Patients: Susceptibility to Fungicides Used in Clinical and Agricultural Settings.J Fungi (Basel). 2021 Sep 21;7(9):784. doi: 10.3390/jof7090784. J Fungi (Basel). 2021. PMID: 34575822 Free PMC article.
References
-
- Cruse, M., R. Telerant, T. Gallagher, T. Lee, and J. W. Taylor. 2002. Cryptic species in Stachybotrys chartarum. Mycologia 94:814-822. - PubMed
-
- de Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
-
- Dignani, M. C., and E. J. Anaissie. 2004. Human fusariosis. Clin. Microbiol. Infect. 1:67-75. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical